Korro Bio KRRO
NASDAQ KRRO
$9.64 -0.07 (-0.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026)

Updated

Korro Bio's Other Accumulated Expenses came in at $105,000 for Q2 2026, down 19.2% from $130,000 a year earlier and down 40.0% from the prior quarter.

Analysis

Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Korro Bio's Other Accumulated Expenses was $70,000, down 74.7% from FY2024.

  • Other Accumulated Expenses carries a three-year compound annual growth rate of -30.3% (FY2022 to FY2025).
  • Going back by year, Other Accumulated Expenses was $277,000 in FY2024 (-38.0%), $447,000 in FY2023 (+115.9%) and $207,000 in FY2022.
  • The five-year range for quarterly Other Accumulated Expenses is $70,000 (Q4 2025) to $493,000 (Q1 2025).
  • Year-over-year, Other Accumulated Expenses has declined for five consecutive quarters, with an average decline of 4.6% over the last seven quarters.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q1 2025 (growth of 252.1%), and the weakest in Q4 2025 (a decline of 74.7%).
  • Business Quant data shows KRRO's Other Accumulated Expenses at $175,000 (Q1 2026), $70,000 (Q4 2025) and $111,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Korro Bio 141.76 Mn -254.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105,000.00
Mar 31, 2026 175,000.00
Dec 31, 2025 70,000.00
Sep 30, 2025 111,000.00
Jun 30, 2025 130,000.00
Mar 31, 2025 493,000.00
Dec 31, 2024 277,000.00
Sep 30, 2024 186,000.00
Jun 30, 2024 247,000.00
Mar 31, 2024 140,000.00
Dec 31, 2023 447,000.00
Dec 31, 2022 207,000.00
Sep 30, 2022 296,000.00
Dec 31, 2019 170,000.00
Sep 30, 2019 16.00 Mn
Dec 31, 2018 161,000.00
API Access

Korro Bio Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KRRO&period=max&api_key=YOUR_API_KEY